{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:02:13Z","timestamp":1794690133616,"version":"4.9.1"},"reference-count":57,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Organon Italia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background\/Objectives: Migraines are a common neurological disorder that significantly impact women, especially during their reproductive years. Hormonal, neurological, and lifestyle factors shape migraine patterns, with fluctuations during menstruation, pregnancy, perimenopause, and menopause influencing migraine prevalence and severity. This expert opinion explores current challenges, therapeutic strategies, and future directions for personalized care, addressing the limited inclusion of women in clinical research across different life stages. Methods: In order to focus on hormonal influences, pharmacological and non-pharmacological therapies, including CGRP monoclonal antibodies, neuromodulation, and lifestyle interventions, a comprehensive analysis of literature, in particular on clinical trials, real-world studies, and guidelines on migraine management was performed. Emerging digital tools and AI-based approaches were also evaluated to improve personalized care for women with migraine. Results: Hormonal therapies, including contraceptives and HRTs, present both risks and benefits, particularly for women with migraines with aura, highlighting the need for individualized approaches. Advances in CGRP-targeted therapies have shown effectiveness in preventing refractory migraines. Non-pharmacological treatments, such as neuromodulation, acupuncture, and lifestyle adjustments, further expand the treatment landscape. However, research gaps remain, particularly regarding hormonal influences on migraines during pregnancy and menopause. Conclusions: Future research should prioritize female-specific clinical trials to better understand the impact of hormonal changes on migraines. Tailored therapies combining pharmacological, non-pharmacological, and digital solutions are essential for improving care. A multidisciplinary approach integrating personalized medicine, technological advancements, and patient education is crucial to optimizing outcomes and enhancing quality of life for women with migraine.<\/jats:p>","DOI":"10.3390\/healthcare13020164","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T04:55:19Z","timestamp":1737003319000},"page":"164","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Framing and Management of Migraines in Women: An Expert Opinion on Challenges, Current Approaches, and Future Multidisciplinary Perspectives"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5670-3755","authenticated-orcid":false,"given":"Piero","family":"Barbanti","sequence":"first","affiliation":[{"name":"Headache and Pain Unit, IRCCS San Raffaele, 00163 Rome, Italy"},{"name":"San Raffaele University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-6396","authenticated-orcid":false,"given":"Rossella E.","family":"Nappi","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy"},{"name":"Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS S. Matteo Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.neurol.2023.01.730","article-title":"Study of severe migraine in general medicine","volume":"179","author":"Henri","year":"2023","journal-title":"Rev. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cevoli, S., Barbanti, P., Finocchi, C., Benedan, L., Mariani, P., Orthmann, N., Bauleo, S., Brusa, P., Cianci, D., and Marozio, L. (2024). Improvement in diagnostic-therapeutic care pathways for women with migraine: An Italian Delphi panel. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1436258"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","article-title":"Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain","volume":"154","author":"Noseda","year":"2013","journal-title":"Pain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2012.02.029","article-title":"Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis","volume":"317","author":"Praline","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14656566.2017.1414182","article-title":"Menstrual migraine: A review of current and developing pharmacotherapies for women","volume":"19","author":"Allais","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10194-012-0424-y","article-title":"Migraine in women: The role of hormones and their impact on vascular diseases","volume":"13","author":"Sacco","year":"2012","journal-title":"J. Headache Pain."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0333102409359315","article-title":"Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine","volume":"30","author":"Pinkerman","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/head.12142","article-title":"Evaluating migraineurs\u2019 preferences for migraine treatment outcomes using a choice experiment","volume":"53","author":"Gonzalez","year":"2013","journal-title":"Headache"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1526-4610.2006.00710.x","article-title":"Hormonal management of migraine associated with menses and the menopause: A clinical review","volume":"47","author":"Loder","year":"2007","journal-title":"Headache"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1129-2377-14-66","article-title":"Hormonal contraception in women with migraine: Is progestogen-only contraception a better choice?","volume":"14","author":"Nappi","year":"2013","journal-title":"J. Headache Pain."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMclde2303811","article-title":"Oral Contraceptives for Menstrual Migraine with Aura","volume":"389","author":"Lee","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102409355601","article-title":"Migraine prevalence by age and sex in the United States: A life-span study","volume":"30","author":"Victor","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3331024241268212","DOI":"10.1177\/03331024241268212","article-title":"Patterns of migraine medication use in Norway: A nationwide registry-based observational study","volume":"44","author":"Stubberud","year":"2024","journal-title":"Cephalalgia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3331024241248846","DOI":"10.1177\/03331024241248846","article-title":"Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study","volume":"44","author":"Mitter","year":"2024","journal-title":"Cephalalgia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10194-023-01625-x","article-title":"Comparative efficacy of different treatments for menstrual migraine: A systematic review and network meta-analysis","volume":"24","author":"Zhang","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Godley, F., Meitzen, J., Nahman-Averbuch, H., O\u2019Neal, M.A., Yeomans, D., Santoro, N., Riggins, N., and Edvinsson, L. (2024). How Sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel Review. J. Pers. Med., 14.","DOI":"10.3390\/jpm14020184"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.62087\/hpr.2024.0003","article-title":"Migraines in Women: A Focus on Reproductive Events and Hormonal Milestones","volume":"25","author":"Kim","year":"2024","journal-title":"Headache Pain Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.maturitas.2020.07.005","article-title":"Menstrual and perimenopausal migraine: A narrative review","volume":"142","author":"MacGregor","year":"2020","journal-title":"Maturitas"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.mayocp.2023.01.010","article-title":"Association of Migraine and Vasomotor Symptoms","volume":"98","author":"Faubion","year":"2023","journal-title":"Mayo Clin. Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2147\/NDT.S285863","article-title":"Patterns of Migraine in Postmenopausal Women: A Systematic Review","volume":"17","author":"Ornello","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s10194-022-01502-z","article-title":"European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure","volume":"23","author":"Sacco","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/head.14476","article-title":"Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment","volume":"63","author":"Schwedt","year":"2023","journal-title":"Headache"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s10194-023-01671-5","article-title":"European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention\u2014Part 3: Topiramate","volume":"24","author":"Raffaelli","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Torbica, A., Rognoni, C., and Tarricone, R. (2021). Investigating Patients\u2019 Preferences to Inform Drug Development Decisions: Novel Insights from a Discrete Choice Experiment in Migraine. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18094916"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/head.14386","article-title":"A stated preference survey to explore patient preferences for novel preventive migraine treatments","volume":"62","author":"Hubig","year":"2022","journal-title":"Headache"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nappi, R.E., Tiranini, L., Sacco, S., De Matteis, E., De Icco, R., and Tassorelli, C. (2022). Role of Estrogens in Menstrual Migraine. Cells, 11.","DOI":"10.3390\/cells11081355"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1474-4422(04)00768-9","article-title":"Oestrogen and attacks of migraine with and without aura","volume":"3","author":"MacGregor","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1586\/ern.11.123","article-title":"Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea","volume":"11","author":"Allais","year":"2011","journal-title":"Expert. Rev. Neurother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40265-013-0099-y","article-title":"Sumatriptan\/naproxen sodium: A review of its use in adult patients with migraine","volume":"73","author":"Yang","year":"2013","journal-title":"Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14656566.2023.2194487","article-title":"Current and emerging pharmacotherapy for menstrual migraine: A narrative review","volume":"24","author":"Ceriani","year":"2023","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1212\/WNL.64.5.931","article-title":"A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine","volume":"64","author":"Adelman","year":"2005","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1526-4610.2001.111006248.x","article-title":"Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, double-blind, placebo-controlled study","volume":"41","author":"Newman","year":"2001","journal-title":"Headache"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200822100-00007","article-title":"Oral zolmitriptan in the short-term prevention of menstrual migraine: A randomized, placebo-controlled study","volume":"22","author":"Tuchman","year":"2008","journal-title":"CNS Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1007\/s10072-007-0783-3","article-title":"Naproxen sodium in short-term prophylaxis of pure menstrual migraine: Pathophysiological and clinical considerations","volume":"28","author":"Allais","year":"2007","journal-title":"Neurol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1111\/j.1526-4610.2008.01309.x","article-title":"Diagnosis and treatment of the menstrual migraine patient","volume":"48","author":"Silberstein","year":"2008","journal-title":"Headache"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1365","DOI":"10.1212\/WNL.0000000000009169","article-title":"Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2","volume":"94","author":"Lipton","year":"2020","journal-title":"Neurology"},{"key":"ref_37","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s10194-017-0815-1","article-title":"Hormonal contraceptives and risk of ischemic stroke in women with migraine: A consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)","volume":"18","author":"Sacco","year":"2017","journal-title":"J. Headache Pain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11916-011-0200-8","article-title":"Headaches during pregnancy","volume":"15","author":"Nappi","year":"2011","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40120-023-00453-0","article-title":"Discrete Choice Experiment to Understand Japanese Patients\u2019 and Physicians\u2019 Preferences for Preventive Treatments for Migraine","volume":"12","author":"Seo","year":"2023","journal-title":"Neurol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ncl.2018.09.004","article-title":"Headache in Pregnancy and the Puerperium","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol. Clin."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrneurol.2015.29","article-title":"Pharmacological treatment of migraine during pregnancy and breastfeeding","volume":"11","author":"Amundsen","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2053369117731172","article-title":"Migraine, menopause and hormone replacement therapy","volume":"24","author":"MacGregor","year":"2018","journal-title":"Post. Reprod. Health"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-021-04010-3","article-title":"Oestrogen engages brain MC4R signalling to drive physical activity in female mice","volume":"599","author":"Krause","year":"2021","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","article-title":"A self-administered screener for migraine in primary care: The ID Migraine validation study","volume":"61","author":"Lipton","year":"2003","journal-title":"Neurology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/head.13498","article-title":"Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment","volume":"59","author":"Mansfield","year":"2019","journal-title":"Headache"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","article-title":"Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: Two randomized controlled trials","volume":"114","author":"Mannix","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1212\/01.wnl.0000335946.53860.1d","article-title":"Excessive acute migraine medication use and migraine progression","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Orlando, B., Egeo, G., Aurilia, C., Fiorentini, G., and Barbanti, P. (2024). Calcitonin Gene-Related Peptide Monoclonal Antibodies: Key Lessons from Real-World Evidence. Brain Sci., 14.","DOI":"10.20944\/preprints202409.0110.v1"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s10194-023-01630-0","article-title":"Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: A phase-III single-blind randomized-controlled trial (the MIND-CM study)","volume":"24","author":"Grazzi","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Deodato, M., Granato, A., Ceschin, M., Galmonte, A., and Manganotti, P. (2022). Algometer Assessment of Pressure Pain Threshold After Onabotulinumtoxin-A and Physical Therapy Treatments in Patients with Chronic Migraine: An Observational Study. Front. Pain Res., 3.","DOI":"10.3389\/fpain.2022.770397"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1007\/s10072-024-07611-8","article-title":"Efficacy of a dual task protocol on neurophysiological and clinical outcomes in migraine: A randomized control trial","volume":"45","author":"Deodato","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/01443615.2016.1234438","article-title":"Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?","volume":"37","author":"Imthurn","year":"2017","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40120-024-00591-z","article-title":"Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study","volume":"13","author":"Barbanti","year":"2024","journal-title":"Neurol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40537-023-00751-2","article-title":"The evolution of Big Data in neuroscience and neurology","volume":"10","author":"Dipietro","year":"2023","journal-title":"J. Big Data"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.apmr.2011.07.198","article-title":"The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain","volume":"92","author":"Louw","year":"2011","journal-title":"Arch. Phys. Med. Rehabil."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/2\/164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:29:35Z","timestamp":1759919375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/2\/164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["healthcare13020164"],"URL":"https:\/\/doi.org\/10.3390\/healthcare13020164","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}